| Financial Year |
March 31 2022 |
| Monetary Funds |
682,693,281.12 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
50,288,777.03 |
| Advances to Suppliers |
1,291,102.38 |
| Other Receivables |
1,406,184.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
8,750,408.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,747,344.28 |
| Total Current Assets |
746,275,822.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
44,855,938.59 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
175,708,414.68 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
967,800.19 |
| Other Non-Current Assets |
561,680.00 |
| Sub-Total of Non-Current Assets |
224,482,977.56 |
| Total Assets |
970,758,799.73 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,534,940.48 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,406,259.00 |
| Taxes Payable |
1,575,817.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,787,185.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,234,109.35 |
| Other Current Liabilities |
1,237.87 |
| Sub-Total of Current Liabilities |
11,859,642.48 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,631,722.73 |
| Total Liabilities |
13,491,365.21 |
| Paid-In Capital(Or Share Stock) |
153,417,600.00 |
| Capital Surplus |
574,394,269.66 |
| Surplus Reserve |
36,468,354.51 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
192,987,210.35 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
957,267,434.52 |
| Owner's Equity（Stockholder's Equity） |
957,267,434.52 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
970,758,799.73 |
